About Bristol-Myers Squibb Company (BMY)
Bristol-Myers Squibb Company is a Drug Manufacturers - General company operating in the Healthcare sector.
BMY trades on the US stock exchanges (NYSE/NASDAQ) and is classified as a large-cap stock .
Key Statistics
- Current Price
- $62.48
- Market Cap
- $127.71B
- 52-Week High
- $68.64
- 52-Week Low
- $45.27
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
$1,000 Invested in Bristol-Myers Squibb Company (BMY)
How much would $1,000 invested in BMY be worth today?
What would $1,000 invested in BMY 1 year ago be worth today?
A $1,000 investment in Bristol-Myers Squibb Company (BMY) in 2025 would be worth $1,431 as of November 2026, representing a +43.0% total return.
What would $1,000 invested in BMY 3 years ago be worth today?
A $1,000 investment in Bristol-Myers Squibb Company (BMY) in 2023 would be worth $1,359 as of November 2026, representing a +35.9% total return.
What would $1,000 invested in BMY 5 years ago be worth today?
A $1,000 investment in Bristol-Myers Squibb Company (BMY) in 2021 would be worth $1,329 as of November 2026, representing a +32.9% total return.
What would $1,000 invested in BMY 10 years ago be worth today?
A $1,000 investment in Bristol-Myers Squibb Company (BMY) in 2016 would be worth $1,783 as of November 2026, representing a +78.3% total return.
What would $1,000 invested in BMY at IPO be worth today?
A $1,000 investment in Bristol-Myers Squibb Company (BMY) at IPO would be worth $224,527 as of November 2026, representing a +22352.7% total return.
Monthly Returns Heatmap
Over the past 54+ years (652 months), Bristol-Myers Squibb Company (BMY) has averaged a monthly return of +1.07% with a median return of +1.12%. The stock had 369 positive months (57%) and 278 negative months (43%). The best month in BMY's history was October 1974 with a +42.1% return, while the worst was April 2002 at -28.4%. Historically, October tends to be the strongest month (averaging +3.3%), and January the weakest (-0.5%).
BMY's longest winning streak was 10 consecutive months of gains, while its longest losing streak was 8 consecutive months of losses. The best full year was 1997 with a cumulative return of +61.5%, and the worst was 2002 at -63.8%.
Annual Returns
Over 54 years of trading history, Bristol-Myers Squibb Company (BMY) has delivered an average annual return of +13.02% with a median return of +13.00%. The compound annual growth rate (CAGR) is +10.32%. The stock posted gains in 41 years (76%) and losses in 13 years (24%).
BMY's best year was 1997 with a +77.07% gain, while the worst was 2002 at -52.40%. The longest streak of consecutive positive years was 18, and the longest losing streak was 2 years. BMY achieved double-digit gains (10%+) in 29 years. It suffered double-digit losses in 7 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | +20.99% | $51.64 | $62.48 |
| 2025 | +0.11% | $51.59 | $51.64 |
| 2024 | +15.81% | $44.55 | $51.59 |
| 2023 | -26.14% | $60.31 | $44.55 |
| 2022 | +18.98% | $50.69 | $60.31 |
| 2021 | +2.88% | $49.27 | $50.69 |
| 2020 | +0.41% | $49.07 | $49.27 |
| 2019 | +27.74% | $38.42 | $49.07 |
| 2018 | -12.90% | $44.10 | $38.42 |
| 2017 | +7.71% | $40.95 | $44.10 |
| 2016 | -13.49% | $47.33 | $40.95 |
| 2015 | +19.26% | $39.69 | $47.33 |
| 2014 | +14.18% | $34.76 | $39.69 |
| 2013 | +69.96% | $20.45 | $34.76 |
| 2012 | -3.80% | $21.26 | $20.45 |
| 2011 | +39.44% | $15.25 | $21.26 |
| 2010 | +8.74% | $14.02 | $15.25 |
| 2009 | +14.83% | $12.21 | $14.02 |
| 2008 | -6.03% | $13.00 | $12.21 |
| 2007 | +4.80% | $12.40 | $13.00 |
| 2006 | +19.90% | $10.34 | $12.40 |
| 2005 | -6.14% | $11.02 | $10.34 |
| 2004 | -7.24% | $11.88 | $11.02 |
| 2003 | +29.14% | $9.20 | $11.88 |
| 2002 | -52.40% | $19.33 | $9.20 |
| 2001 | -26.16% | $26.18 | $19.33 |
| 2000 | +17.10% | $22.35 | $26.18 |
| 1999 | -2.80% | $23.00 | $22.35 |
| 1998 | +42.95% | $16.09 | $23.00 |
| 1997 | +77.07% | $9.09 | $16.09 |
| 1996 | +32.16% | $6.88 | $9.09 |
| 1995 | +53.30% | $4.48 | $6.88 |
| 1994 | +6.11% | $4.23 | $4.48 |
| 1993 | -9.46% | $4.67 | $4.23 |
| 1992 | -21.18% | $5.92 | $4.67 |
| 1991 | +35.82% | $4.36 | $5.92 |
| 1990 | +24.08% | $3.51 | $4.36 |
| 1989 | +28.88% | $2.73 | $3.51 |
| 1988 | +14.40% | $2.38 | $2.73 |
| 1987 | +2.84% | $2.32 | $2.38 |
| 1986 | +27.54% | $1.82 | $2.32 |
| 1985 | +30.56% | $1.39 | $1.82 |
| 1984 | +28.17% | $1.09 | $1.39 |
| 1983 | +30.52% | $0.83 | $1.09 |
| 1982 | +31.20% | $0.63 | $0.83 |
| 1981 | +9.13% | $0.58 | $0.63 |
| 1980 | +40.53% | $0.41 | $0.58 |
| 1979 | +7.87% | $0.38 | $0.41 |
| 1978 | +10.25% | $0.35 | $0.38 |
| 1977 | +1.32% | $0.34 | $0.35 |
| 1976 | +2.09% | $0.34 | $0.34 |
| 1975 | +40.95% | $0.24 | $0.34 |
| 1974 | +11.81% | $0.21 | $0.24 |
| 1973 | -30.94% | $0.31 | $0.21 |
Frequently Asked Questions: BMY
What sector is BMY in? ▼
BMY operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has BMY performed historically? ▼
Over 54 years of trading history, BMY has posted gains in 41 years (76% of the time). The best year was 1997 with a +77.1% return. Past performance does not guarantee future results.
How can I invest in BMY? ▼
You can invest in BMY through any brokerage account that offers access to US stock exchanges. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold BMY.
Last updated: 11/1/2026